Each domain is assessed using questions with an overall evaluation of low risk, some concerns, or high risk of bias
Accordingly, the therapeutic approach is to lower catalytic iron and interrupt chain propagation by combining chelation (e.g., deferoxamine or deferiprone) with restraint of ferritinophagy (NCOA4) to curb Fe release, managing HO-1 induction so heme breakdown does not overexpand LIP, restoring GPX4 capacity via selenium sufficiency and GSH support and deploying radical-trapping antioxidants (ferrostatin-1, liproxstatin-1) to terminate lipid-radical chains
This is your journey, and it should fit you
The few metabolic studies show only minor improvements in insulin sensitivity or digestion, without consistent body weight loss
Common causes include bloating or constipation, gallbladder issues, kidney stones or infection, pancreatitis, and menstrual cycle or hormonal changes